APG Asset Management N.V. Decreases Holdings in Agilent Technologies, Inc. $A

Key Points

• APG Asset Management N.V. reduced its stake in Agilent Technologies by 3.7%, owning approximately 0.06% of the company after selling 6,417 shares, which are now valued at $18,241,000.
• Insider trading revealed that CEO Padraig Mcdonnell sold 1,508 shares, representing a 3.87% decrease in ownership, for a total of $177,099.52.
• Agilent Technologies has set FY 2025 earnings guidance at $5.540-5.610 EPS and reported Q1 earnings of $1.31 per share, exceeding analysts' expectations.

APG Asset Management N.V. trimmed its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 3.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 168,441 shares of the medical research company's stock after selling 6,417 shares during the period. APG Asset Management N.V. owned about 0.06% of Agilent Technologies worth $18,241,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Brighton Jones LLC increased its stake in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after buying an additional 270 shares during the period. TD Waterhouse Canada Inc. boosted its holdings in Agilent Technologies by 48.7% in the fourth quarter. TD Waterhouse Canada Inc. now owns 443 shares of the medical research company's stock valued at $60,000 after acquiring an additional 145 shares during the last quarter. IHT Wealth Management LLC increased its position in Agilent Technologies by 21.5% during the 4th quarter. IHT Wealth Management LLC now owns 1,919 shares of the medical research company's stock valued at $258,000 after purchasing an additional 339 shares during the period. Dark Forest Capital Management LP raised its holdings in Agilent Technologies by 93.4% during the 4th quarter. Dark Forest Capital Management LP now owns 3,730 shares of the medical research company's stock worth $501,000 after purchasing an additional 1,801 shares during the last quarter. Finally, Integrated Wealth Concepts LLC raised its holdings in Agilent Technologies by 24.5% during the 4th quarter. Integrated Wealth Concepts LLC now owns 3,413 shares of the medical research company's stock worth $458,000 after purchasing an additional 671 shares during the last quarter.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on A shares. Leerink Partners increased their price objective on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Friday, May 30th. TD Cowen upped their price target on shares of Agilent Technologies to $150.00 and gave the company a "buy" rating in a research report on Thursday, May 29th. Robert W. Baird lifted their price objective on Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a research report on Thursday. JPMorgan Chase & Co. dropped their price objective on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research note on Thursday, May 29th. Finally, Evercore ISI decreased their target price on Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating for the company in a research note on Thursday. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $139.25.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the transaction, the chief executive officer directly owned 37,448 shares in the company, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Agilent Technologies Stock Up 5.5%

Shares of A traded up $6.48 on Thursday, reaching $125.17. The company's stock had a trading volume of 3,886,267 shares, compared to its average volume of 1,953,399. The stock has a market capitalization of $35.56 billion, a PE ratio of 30.91, a PEG ratio of 3.59 and a beta of 1.22. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The firm has a fifty day moving average of $117.99 and a 200-day moving average of $116.89.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%.The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the business posted $1.32 earnings per share. The company's quarterly revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.